5th Annual Stefan S. Fajans Lecture in Diabetes, 2013-14
and U-M Internal Medicine Grand Rounds Lecture
Phillip Gorden, M.D.
Stefan S. Fajans, M.D.
Friday, October 18, 2013
Ford Amphitheater, 2nd floor
1500 E. Medical Center Drive
Ann Arbor, MI 48109
"Syndromic Insulin Resistance: Models for the
Therapeutic Basis of Metabolic Disease"
Phillip Gorden, M.D.
Director Emeritus and Senior Investigator
National Institutes of Diabetes and Digestive and Kidney Disease
National Institutes of Health
This annual lecture in honor of Dr. Stefan S. Fajans, sponsored by the University of Michigan Division of Metabolism, Endocrinology & Diabetes, recognizes a renowned diabetes investigator and/or physician who has made significant contributions to the field.
The 2013-14 Stefan S. Fajans Lecture in Diabetes will be given by Phillip Gorden, M.D., Director Emeritus and Senior Investigator of the National Institutes of Diabetes and Digestive and Kidney Disease at the National Institutes of Health.
Dr. Phillip Gorden received his BA degree from Vanderbilt University, and an MD degree from Vanderbilt University School of Medicine. He then spent 5 years in medical residency, and completed an endocrine and metabolism fellowship at Yale University School of Medicine. In 1966, he came to the National Institutes of Health (NIH), as a clinical investigator. His early studies include the heterogeneity of polypeptide hormones, including the pro-insulin-like components of plasma, and clinical descriptions of diseases of extreme insulin resistance; particularly as related to the insulin receptor. From 1976 to 1978 he was a visiting professor in the laboratory of Lelio Orci, MD in Geneva, Switzerland, and collaborated extensively with Jean-Louis Carpentier, MD on receptor mediated endocytosis of polypeptide hormones.
Following his return to the NIH, he served as a major branch chief, and as clinical director of the National Institute of Diabetes Digestive and Kidney Diseases (NIDDK). During his tenure as director of NIDDK from 1986-1999, a number of major clinical trials were accomplished. These include the Diabetes Control and Complication Trial (DCCT), and its epidemiological follow-up (EDIC), as well as the diabetes prevention trial in Type 1 diabetes (DPT) and the Diabetes Prevention Program (DPP), which demonstrated a mechanism to prevent Type 2 diabetes. Dr. Gorden’s tenure as NIDDK director also coincided with the doubling of the NIH budget, which included a marked increase in NIDDK resources and the special appropriations for Type 1 Diabetes research of 150 million dollars per year.
In 1999 Dr. Gorden returned full time to the intramural program of NIDDK, where he is focused on developing therapeutic strategies for the extreme forms of insulin resistance, such as lipodystrophy and autoantibodies to the insulin receptor. He has received a number of national and international awards, including lectureships and honorary degrees, and has published over 370 scientific papers.
~ ~ ~ ~ ~ ~ ~ ~
Since this is also an Internal Medicine Grand Rounds lecture, box lunches and bottled water will be available from 11:45 a.m.-12:10 p.m. (or until gone.) The lunches are provided by the Department of Internal Medicine for Grand Rounds attendees.
Departmental Grand Rounds can be accessed in real time via interactive video over the internet by clicking on the enclosed link at the time of the event: https://connect.umms.med.umich.edu/intmedg
Questions: Annette Murphy, (734) 763-3056 or email@example.com
~ ~ ~ ~ ~ ~ ~ ~
Stefan S. Fajans, M.D., Active Professor Emeritus in the Department of Internal Medicine, Division of Metabolism, Endocrinology & Diabetes, became a member of the University of Michigan Medical School faculty in 1949. He served as Chief of the Division of Endocrinology & Metabolism from 1973 to 1987 and as the Director of the University of Michigan Diabetes Research and Training Center from 1977 to 1986. Dr. Fajans devoted a large portion of his scientific career to the study of diabetes and made important contributions to the understanding of its etiology, diagnosis, and treatment. For more on his work and career, please see this bio of Dr. Stefan S. Fajans [PDF].